Stephan A. Veltkamp

New insights into the pharmacology and cytotoxicity of gemcitabine and 2′,2′-difluorodeoxyuridine

Stephan A. Veltkamp, Dick Pluim, Maria A.J. van Eijndhoven et al. · Molecular Cancer Therapeutics · 2008 · 97 citations

Medicine, Pharmacokinetics, Pharmacology +14

Renal Glucose Handling

Ele Ferrannini, Stephan A. Veltkamp, Ronald Smulders et al. · Diabetes Care · 2013 · 81 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Oral Administration of Gemcitabine in Patients with Refractory Tumors: A Clinical and Pharmacologic Study

Stephan A. Veltkamp, Robert S. Jansen, Sophie Callies et al. · Clinical Cancer Research · 2008 · 77 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +17

Quantitative analysis of gemcitabine triphosphate in human peripheral blood mononuclear cells using weak anion‐exchange liquid chromatography coupled with tandem mass spectrometry

Stephan A. Veltkamp, M. J. X. Hillebrand, Hilde Rosing et al. · Journal of Mass Spectrometry · 2006 · 62 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Effect of Ipragliflozin (ASP1941), a Novel Selective Sodium-Dependent Glucose Co-Transporter 2 Inhibitor, on Urinary Glucose Excretion in Healthy Subjects

Stephan A. Veltkamp, Takeshi Kadokura, Walter Krauwinkel et al. · Clinical Drug Investigation · 2011 · 55 citations

Medicine, Endocrinology, Pharmacology +13